Gold prices gained on Friday as recent U.S. inflation ‌data weighed on the dollar and led markets to slightly trim rate-hike bets.

Gold prices ​remained near a ​more than seven-month low, as expectations of U.S. interest rate hikes weighed on the precious metal.

Gold futures tumbled more than 3% on Wednesday, trading below $4,000 per troy ounce. What's behind the move: The precious metal declined as the US dollar rose and i

Gold prices fell to a more than seven-month low on Wednesday, after ‌briefly slipping below the key $4,000-per-ounce level, under pressure from a firmer U.S. dollar and growing expectations of interest rate hikes.

Crude oil futures turned higher today, pausing a decline that has brought prices virtually back down to the level they were before the Iran war started. Brent crude futures settled higher after report

Global prices fell to near their pre-Iran war level after the United States unblocked international Iranian oil sales and ships transit Hormuz Strait.

Oil prices continued to fall on Wednesday as efforts to move ships out of the Persian Gulf have made headway, increasing the flow of crude oil through the Strait of Hormuz, a critical shipping route for crude oil.

Oil prices slipped back to levels seen before the Iran war as tanker traffic through the Strait of Hormuz picked up and a wave of supply trapped inside the Persian Gulf for months started flowing again.

SpaceX’s post-IPO swings pushed Musk back below $1 trillion. The line may keep moving. Elon Musk is no longer a trillionaire—for now. The founder is back below $1 trillion, less than two weeks after SpaceX’s public-market debut briefly pushed his paper fortune past the mark.

Elon Musk lost his trillionaire status on Tuesday after a brutal global tech rout erased billions from his wealth.

The world's largest personal fortune is back to being denominated in billions with SpaceX trading about 30% off its post-IPO high.

Elon Musk is no stranger to financial alchemy. His latest feat: adding billions of dollars of debt onto his cash-burning business empire while simultaneously cutting its annual interest burden.

The Federal Reserve's preferred inflation gauge climbed to 4.1% in May, its highest level in more than three years. Josh Schafer, Barron's Investor Circle Newsletter editor, joins with analysis.

The personal-consumption expenditures price index climbed by 0.4% in May, maintaining the same growth of 0.4% in April, the Commerce Department said.

Inflation continued to rise in May, with the Personal Consumption Expenditures price index rising at an annual rate of 4.1%.

The US Federal Reserve's preferred inflation measure hit a fresh three-year high in May, as elevated energy prices from President Donald Trump's Iran war pose a key test to his Republican Party ahead of midterm elections.

Chip stocks are broadly seeing momentum following Micron's earnings report. Shares of Marvell Technology and Intel are up more than 4%, while shares of Arm Holdings are up more than 6%. Nvidia's stock is ahead about 1%.

Micron Technology stock surged ahead of the open Thursday after the memory chip maker reported strong third-quarter earnings. Micron reported adjusted earnings per share of $25.11. That’s up from $1.91 a share last year,

Chip and AI-related stocks edged higher on Wednesday, showing signs of recovery from Tuesday onslaught that was led by memory stocks including Micron Technology (MU), which reports today post market.

Micron posted its third-quarter earnings after Wednesday's closing bell, with the report serving as a major barometer for the AI trade.

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the German pharma and technology group’s biggest acquisition in more than a decade.

Merck will buy Minneapolis-based Bio-Techne Corp. in a deal worth $11.3 billion. Bio-Techne was under pressure from an activist investor that was pressing for a sale, according to Bloomberg. For Merck,

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the Minneapolis-based group Bio-Techne, according to a news release posted Thursday.

German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne Corp for $11.3 billion, its largest deal in over a decade, as it looks to strengthen its life sciences business.